ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1432

Long-term Radiographic Progression in Early versus Established Axial Spondyloarthritis: A 12-Year Observational Study

Tae-Hwan Kim1, Bora Nam2, Jung Ho Yang3, So-Young Bang4, Ji Hui Shin5, Seunghun Lee6 and Tae-jong Kim7, 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 2Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Department of Preventive Medicine, Graduate School of Chonnam National University, Gwangju, Republic of Korea, 4Hanyang University, Seoul, Republic of Korea, 5Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 6College of Medicine, Hanyang University, Seoul, Republic of Korea, 7Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwang-Ju, South Korea

Meeting: ACR Convergence 2025

Keywords: Outcome measures, radiography, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: This study evaluates the impact of the ASAS definition of early axial spondyloarthritis (axSpA) on radiographic progression over a 12-year period, utilizing the Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) to compare early and established disease stages.

Methods: Data from the Korean spondyloarthropathy registry were used in this retrospective observational study to categorize patients into early or established axSpA according to the ASAS criteria. Radiographic progression was assessed through annual changes in mSASSS, scored independently by two radiologists. Linear regression and other statistical analyses were performed to examine the correlation between early axSpA status and radiographic progression, adjusting for relevant covariates.

Results: The study included time intervals at 0-4, 0-6, 0-8, 0-10, and 0-12 years, involving 445 patients. Results showed no statistically significant differences in mSASSS changes between the early and established axSpA groups, suggesting similar rates of progression irrespective of TNF-α blocker therapy. Both univariable and multivariable analyses demonstrated that early axSpA status did not significantly impact changes in mSASSS.

Conclusion: Our findings indicate that the ASAS criteria for early stage axSpA do not significantly affect long-term radiographic outcomes, challenging the assumption that early identification and treatment of axSpA based on these criteria alter radiographic progression.

Supporting image 1Table 1

Supporting image 2Table 2


Disclosures: T. Kim: Samsung Bioepis, 5; B. Nam: None; J. Yang: None; S. Bang: None; J. Shin: None; S. Lee: None; T. Kim: None.

To cite this abstract in AMA style:

Kim T, Nam B, Yang J, Bang S, Shin J, Lee S, Kim T. Long-term Radiographic Progression in Early versus Established Axial Spondyloarthritis: A 12-Year Observational Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/long-term-radiographic-progression-in-early-versus-established-axial-spondyloarthritis-a-12-year-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-term-radiographic-progression-in-early-versus-established-axial-spondyloarthritis-a-12-year-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology